Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, distinguishing it from licensed agents such as semaglutide or tirzepatide
Let our medical aestheticians help you create a plan tailored to your aesthetic needs
The majority of patients had no rectal bleeding at all and also had fewer daily bowel movements at about 4 years .* Clinical trials of STELARA included patients who failed or were intolerant to other medications, including a biologic, prior to STELARA
It is specifically recommended for those with IBD as the natural levels of calcium are often impacted by medicines such as corticosteroids
44 A small absolute increased risk of specific malignancies with thiopurines has been described
Ytterberg SR, Bhatt DL, Connell CA